UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma

Annals of hematology, 2020-10, Vol.99 (10), p.2385-2392

2020

Volltextzugriff (PDF)

Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement

Pathology oncology research, 2023-06, Vol.29, p.1611250-1611250

2023

Volltextzugriff (PDF)

Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary

Annals of hematology, 2023-09, Vol.102 (9), p.2555-2563

2023

Volltextzugriff (PDF)

Immune response against the severe acute respiratory syndrome coronavirus 2

Orvosi hetilap, 2022-05, Vol.163 (20), p.774

2022

Volltextzugriff (PDF)

Detection of microchimerism with high sensitivity droplet digital PCR technique and its significance in monitoring of hematopoietic stem cell transplanted patients

Orvosi hetilap, 2024-02, Vol.165 (8), p.297

2024

Volltextzugriff (PDF)

Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2020-01, Vol.55 (1), p.215-223

2020

Volltextzugriff (PDF)

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Frontiers in immunology, 2021-03, Vol.12, p.663187-663187

2021

Volltextzugriff (PDF)

Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality

Thrombosis and haemostasis, 2022-02, Vol.122 (2), p.240

2022

Volltextzugriff (PDF)

Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation

International journal of molecular sciences, 2019-09, Vol.20 (18), p.4450

2019

Volltextzugriff (PDF)

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia

PloS one, 2021-06, Vol.16 (6), p.e0253386-e0253386

2021

Volltextzugriff (PDF)

Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol

Pathology oncology research, 2024-05, Vol.30, p.1611720

2024

Volltextzugriff (PDF)

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study

International journal of infectious diseases, 2022-12, Vol.125, p.233-240

2022

Volltextzugriff (PDF)

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature

Journal of oncology, 2018-01, Vol.2018, p.3970169-7

2018

Volltextzugriff (PDF)

Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy-Analysis of 130 Eyes of 65 Subjects

Journal of clinical medicine, 2022-03, Vol.11 (7), p.1848

2022

Volltextzugriff (PDF)

Evaluation of Retinal Blood Flow in Patients with Monoclonal Gammopathy Using OCT Angiography

Journal of clinical medicine, 2023-08, Vol.12 (16), p.5227

2023

Volltextzugriff (PDF)

Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects

Journal of ophthalmology, 2021, Vol.2021, p.9982875-8

2021

Volltextzugriff (PDF)

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

Frontiers in immunology, 2023-03, Vol.14, p.1162171-1162171

2023

Volltextzugriff (PDF)

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study

Journal of clinical medicine, 2023-07, Vol.12 (15), p.5000

2023

Volltextzugriff (PDF)

Succesful systemic treatment of monoclonal gammopathy with corneal significance (MGCS) ‐ a case report

Acta ophthalmologica (Oxford, England), 2022-12, Vol.100 (S275), p.n/a

2022

Volltextzugriff (PDF)

Investigation of TGFB1 -1347CT variant as a biomarker after allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2020-01, Vol.55 (1), p.215

2020

Volltextzugriff (PDF)

Anti-cytokine therapy in novel coronavirus disease (COVID-19) – the first administration of tocilizumab in Hungary at a department of infectology

Orvosi hetilap, 2020-06, Vol.161 (26), p.1070

2020

Volltextzugriff (PDF)

Baricitinib versus tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: A prospective, investigational, real-world study

International journal of infectious diseases, 2022-10

2022

Volltextzugriff (PDF)

Familial multiple myeloma. Two more families

Central European journal of medicine, 2009-12, Vol.4 (4), p.501-505

2009

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(46)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma

Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement

Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary

Immune response against the severe acute respiratory syndrome coronavirus 2

Detection of microchimerism with high sensitivity droplet digital PCR technique and its significance in monitoring of hematopoietic stem cell transplanted patients

Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality

Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia

Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature

Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy-Analysis of 130 Eyes of 65 Subjects

Evaluation of Retinal Blood Flow in Patients with Monoclonal Gammopathy Using OCT Angiography

Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study

Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review

Succesful systemic treatment of monoclonal gammopathy with corneal significance (MGCS) ‐ a case report

Investigation of TGFB1 -1347CT variant as a biomarker after allogeneic hematopoietic stem cell transplantation

Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study

Anti-cytokine therapy in novel coronavirus disease (COVID-19) – the first administration of tocilizumab in Hungary at a department of infectology

Baricitinib versus tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: A prospective, investigational, real-world study

Familial multiple myeloma. Two more families

Suchergebnisse filtern